Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 962-968
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.962
Table 4 Metabolic variables at baseline and 6 wk after flavonoid-rich or placebo supplementation in both groups
Groups
InterventionControlPa
n = 19n = 17
TC in mg/L
Baseline179.01 ± 31.86196.35 ± 50.50.19
6 wk165.9 ± 32.4183.29 ± 49.90.07
Change 0-6 wk-13.1 ± 16.45-13.05 ± 420.80
%CI for change-7.57 to 20.32-8.5 to 34.67
P for change within group0.00010.216
LDL-C in mg/dL
Baseline95.84 ± 26.45116.51 ± 48.80.13
6 wk92.96 ± 28.03108.19 ± 40.20.19
Change 0-6 wk-2.87 ± 0.47-8.3 ± 0.130.60
%CI for change-6.8 to 12.53-15.52 to -32.17
P for change within group0.540.46
HDL-C in mg/dL
Baseline47.38 ± 13.6746.54 ± 12.320.84
6 wk48.36 ± 12.6247.7 ± 12.260.88
Change 0-6 wk0.97 ± 2.41.2 ± 3.10.78
%CI for change-2.1 to 0.18-2.8 to 0.38
P for change within group0.0980.12
TGs in mg/dL
Baseline184.6 ± 87.6195.2 ± 84.20.81
6 wk166.37 ± 99.59183.2 ± 84.40.65
Change 0-6 wk-18.28 ± 58.7-11.88 ± 90.560.80
%CI for change-10.5 to 46.6-34.6 to 58.4
P for change within group0.190.59
TC/HDL-C
Baseline3.9 ± 0.884.4 ± 1.50.19
6 wk3.6 ± 0.824.3 ± 1.20.29
Change 0-6 wk-0.28 ± 0.35-0.35 ± 0.080.40
%CI for change0.11 to 0.45-0.06 to 1.01
P for change within group0.00210.08
LDL-C/HDL-C
Baseline2.1 ± 0.682.6 ± 1.20.16
6 wk1.9 ± 0.622.3 ± 0.940.24
Change 0-6 wk-0.12 ± 0.36-0.27 ± 0.060.57
%CI for change0.11 to 0.45-0.06 to 1.01
P for change within group0.1830.33
SBP in mmHg
Baseline129.95 ± 14.9127.6 ± 15.60.74
6 wk114.3 ± 27.5122.9 ± 14.470.25
Change 0-6 wk-15.94 ± 27.98-4.7 ± 6.20.57
%CI for change2.45 to 29.431.49 to 7.91
P for change within group0.02310.0071
DBP in mmHg
Baseline84.2 ± 8.0386.76 ± 6.30.168
6 wk78.7 ± 7.284.4 ± 5.80.0141
Change 0-6 wk-5.5 ± 7-2.3 ± 6.70.16
%CI for change0.11 to 0.45-0.06 to 1.01
P for change within group0.00310.134